Literature DB >> 22924938

Novel antiviral therapeutics to control foot-and-mouth disease.

Camila C Dias1, Mauro P Moraes, Marcelo Weiss, Fayna Diaz-San Segundo, Eva Perez-Martin, Andres M Salazar, Teresa de los Santos, Marvin J Grubman.   

Abstract

Foot-and-mouth disease virus (FMDV) causes a highly contagious disease of cloven-hoofed animals. Vaccines require ∼7 days to induce protection; thus, before this time, vaccinated animals are still susceptible to the disease. Our group has previously shown that swine inoculated with 1×10(11) focus forming units (FFU) of a replication-defective human adenovirus containing the gene for porcine interferon alpha (Adt-pIFN-α) are sterilely protected from FMDV serotypes A24, O1 Manisa, or Asia 1 when the animals are challenged 1 day postadministration, and protection can last for 3-5 days. Polyriboinosinic-polyribocytidylic acid stabilized with poly-l-lysine and carboxymethyl cellulose (poly ICLC) is a synthetic double-stranded RNA that is a viral mimic and activates multiple innate immune pathways through interaction with toll-like receptor 3 and MDA-5. It is a potent inducer of IFNs. In this study, we initially examined the effect of poly IC and IFN-α on FMDV replication and gene induction in cell culture. Poly ICLC alone or combined with Adt-pIFN-α was then evaluated for its therapeutic efficacy in swine against intradermal challenge with FMDV A24, 1 day post-treatment. Groups of swine were subcutaneously inoculated either with poly ICLC alone (4 or 8 mg) or in combination with different doses of Adt-pIFN-α (2.5×10(9), 1×10(9), or 2.5×10(8) FFU). While different degrees of protection were achieved in all the treated animals, a dose of 8 mg of poly ICLC alone or combined with 1×10(9) FFU of Adt-pIFN-α was sufficient to sterilely protect swine when challenged 24 h later with FMDV A24. IFN-stimulated gene (ISG) expression in peripheral blood mononuclear cells at 1 day post-treatment was broader and higher in protected animals than in nonprotected animals. These data indicate that poly ICLC is a potent stimulator of IFN and ISGs in swine and at an adequate dose is sufficient to induce complete protection against FMD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22924938     DOI: 10.1089/jir.2012.0012

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  14 in total

1.  BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.

Authors:  Aro Kim; Gyeongmin Lee; Ji-Hyeon Hwang; Jong-Hyeon Park; Min Ja Lee; Byounghan Kim; Su-Mi Kim
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

2.  Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Diaz-San Segundo; Elizabeth Ramirez-Medina; Luis L Rodríguez; Teresa de Los Santos
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

3.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

4.  Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus.

Authors:  Fayna Diaz-San Segundo; Camila C A Dias; Mauro P Moraes; Marcelo Weiss; Eva Perez-Martin; Gary Owens; Max Custer; Kurt Kamrud; Teresa de los Santos; Marvin J Grubman
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

5.  Repeated exposure to 5D9, an inhibitor of 3D polymerase, effectively limits the replication of foot-and-mouth disease virus in host cells.

Authors:  Devendra K Rai; Elizabeth A Schafer; Kamalendra Singh; Mark A McIntosh; Stefan G Sarafianos; Elizabeth Rieder
Journal:  Antiviral Res       Date:  2013-04-08       Impact factor: 5.970

6.  In vitro antiviral efficacy of pleconaril and ribavirin on foot-and-mouth disease virus replication.

Authors:  Sarkar Soumajit; Ramasamy Periyasamy Tamil Selvan; Veerakyathappa Bhanuprakash
Journal:  Virusdisease       Date:  2019-12-05

Review 7.  The Pathogenesis of Foot-and-Mouth Disease in Pigs.

Authors:  Carolina Stenfeldt; Fayna Diaz-San Segundo; Teresa de Los Santos; Luis L Rodriguez; Jonathan Arzt
Journal:  Front Vet Sci       Date:  2016-05-23

Review 8.  Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective.

Authors:  Raj Kumar Singh; Gaurav Kumar Sharma; Sonalika Mahajan; Kuldeep Dhama; Suresh H Basagoudanavar; Madhusudan Hosamani; B P Sreenivasa; Wanpen Chaicumpa; Vivek Kumar Gupta; Aniket Sanyal
Journal:  Vaccines (Basel)       Date:  2019-08-16

Review 9.  Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs.

Authors:  Nicholas A Lyons; Young S Lyoo; Donald P King; David J Paton
Journal:  Front Vet Sci       Date:  2016-11-30

10.  Low-dose oral interferon modulates expression of inflammatory and autoimmune genes in cattle.

Authors:  Stephen W Mamber; Jeremy Lins; Volkan Gurel; David P Hutcheson; Pablo Pinedo; David Bechtol; Steven Krakowka; Rachel Fields-Henderson; Joseph M Cummins
Journal:  Vet Immunol Immunopathol       Date:  2016-03-04       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.